- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07861269
Characterization of Hamstring and Quadriceps Neuromuscular Fatigue After Consecutive Soccer Trainings in Soccer Players (QIF2)
September 30, 2026 updated by: University Hospital, Strasbourg, France
This is a monocentric study assessing hamstring and quadriceps neuromuscular fatigue after 3 consecutive soccer trainings. The purpose of this study was:
- To quantify the difference of isometric force immediately after a simulated soccer training.
- To characterize peripheral and central fatigue between hamstring and quadriceps muscles.
- To compare the level neuromuscular fatigue before each session, to assess the cumulative effect of neuromuscular fatigue
- To highlight correlation between neuromuscular fatigue and performance markers.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- to be a soccer player, licensed to the French Football Federation
- affiliation to the social health insurance scheme
Exclusion Criteria:
- impossibility to give the subject enlightened information (subject in emergency situation, difficulties in understanding the study, …)
- subject under the protection of justice
- subject under guardianship or curatorship
- lower limbs musculotendinous or articular problems
- smoker or having been a smoker in the last 5 years
- subject wearing a pacemaker
- drug treatment in progress and impossibility to stop it within 7 days before the beginning of the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physical exercices arm
|
contractions and electric impulses |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pre- to Post-Exercise Change in Maximal Isometric Knee Flexor and Extensor Strength
Time Frame: Before and immediately post exercise (i.e., during the first minute after cessation of exercise).
|
Before and immediately post exercise (i.e., during the first minute after cessation of exercise).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
July 1, 2028
Study Registration Dates
First Submitted
September 30, 2026
First Submitted That Met QC Criteria
September 30, 2026
First Posted (Actual)
October 6, 2026
Study Record Updates
Last Update Posted (Actual)
October 6, 2026
Last Update Submitted That Met QC Criteria
September 30, 2026
Last Verified
September 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- RC26_0128
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.